Company Overview
Snapshot
Founded in April 2015 by Ofer Yodfat and Guy Shinar, Triple Jump operates with 11–50 employees. The company has secured funding across one round from four investors, with Medtronic and Dov Moran identified as investors. In September 2020, Medtronic invested $20 million into the company.
Business overview
Triple Jump is an Israeli Health Tech & Life Sciences company focused on developing an innovative, compact insulin pump patch for diabetes patients. This device is designed for body placement, features mobile connectivity, and is intended for integration into future artificial pancreas systems. The Triple Jump system includes a portable, battery-operated miniature insulin pump, a hand-held controller, and supporting accessories, serving the medical devices and drug delivery sectors.
Strategic signal
In October 2021, Medtronic was reportedly in talks to acquire Triple Jump for $300 million. This indicates significant strategic interest from a major medical device corporation in Triple Jump's insulin pump technology, signaling potential for a high-value exit and validation of the company's product development.
Log in to access full profile ›Company Intelligence Q&A
- When was Triple Jump founded and by whom?
- Triple Jump was founded in April 2015 by Ofer Yodfat and Guy Shinar.
- Which company made a significant investment in Triple Jump?
- In September 2020, Medtronic invested $20 million in Triple Jump, as reported by Calcalistech.com.
- What was the reported acquisition interest in Triple Jump?
- In October 2021, Medtronic was reportedly in talks to acquire Triple Jump for $300 million.
- What is the employee count for Triple Jump?
- Triple Jump has 11–50 employees.